-
公开(公告)号:US20060173002A1
公开(公告)日:2006-08-03
申请号:US11333050
申请日:2006-01-17
申请人: James Sutton , Zulan Pi , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Patrick Lam
发明人: James Sutton , Zulan Pi , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Patrick Lam
IPC分类号: A61K31/498 , A61K31/4745 , A61K31/43 , A61K31/428
CPC分类号: C07D213/74 , C07D213/75 , C07D213/80 , C07D277/42 , C07D277/56 , C07D401/12 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D487/04 , C07D513/04
摘要: The present invention provides novel heteroaryl compounds and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
摘要翻译: 本发明提供了新的杂芳基化合物及其类似物,它们是人P2Y 1受体的选择性抑制剂。 本发明还提供了相同的各种药物组合物以及治疗对P2Y受体活性的调节作用的疾病的方法。
-
公开(公告)号:US08273772B2
公开(公告)日:2012-09-25
申请号:US12619702
申请日:2009-11-17
申请人: James C. Sutton , Zulan Pi , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Patrick Y. S. Lam
发明人: James C. Sutton , Zulan Pi , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Patrick Y. S. Lam
IPC分类号: A61K31/4436 , C07D417/12
CPC分类号: C07D213/74 , C07D213/75 , C07D213/80 , C07D277/42 , C07D277/56 , C07D401/12 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D487/04 , C07D513/04
摘要: The present invention provides novel heteroaryl compounds and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
摘要翻译: 本发明提供了新的杂芳基化合物及其类似物,它们是人P2Y1受体的选择性抑制剂。 本发明还提供了相同的各种药物组合物以及治疗对P2Y1受体活性调节作用的疾病的方法。
-
公开(公告)号:US20100093689A1
公开(公告)日:2010-04-15
申请号:US12619702
申请日:2009-11-17
申请人: James C. Sutton , Zulan Pi , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Patrick Y.S. Lam
发明人: James C. Sutton , Zulan Pi , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Patrick Y.S. Lam
IPC分类号: A61K31/4439 , C07D417/12 , C07D417/14 , C07D413/12 , C07D487/04 , C07D513/04 , A61K31/4545 , A61K31/496 , A61K31/444 , A61K31/4985 , A61K31/437
CPC分类号: C07D213/74 , C07D213/75 , C07D213/80 , C07D277/42 , C07D277/56 , C07D401/12 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D487/04 , C07D513/04
摘要: The present invention provides novel heteroaryl compounds and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
摘要翻译: 本发明提供了新的杂芳基化合物及其类似物,它们是人P2Y1受体的选择性抑制剂。 本发明还提供了相同的各种药物组合物以及治疗对P2Y1受体活性调节作用的疾病的方法。
-
4.Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions 有权
标题翻译: P2Y1受体的尿素拮抗剂可用于治疗血栓形成公开(公告)号:US20050267119A1
公开(公告)日:2005-12-01
申请号:US11126915
申请日:2005-05-11
申请人: Hannguang Chao , Huji Tuerdi , Timothy Herpin , Jacques Roberge , Yalei Liu , R. Lawrence , Robert Rehfuss , Charles Clark , Jennifer Qiao , Timur Gungor , Patrick Lam , Tammy Wang , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Gilles Bouthillier , Dora Schnur
发明人: Hannguang Chao , Huji Tuerdi , Timothy Herpin , Jacques Roberge , Yalei Liu , R. Lawrence , Robert Rehfuss , Charles Clark , Jennifer Qiao , Timur Gungor , Patrick Lam , Tammy Wang , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Gilles Bouthillier , Dora Schnur
IPC分类号: A61K31/4439 , A61K31/444 , A61K31/501 , C07C275/30 , C07C275/32 , C07D213/40 , C07D213/75 , C07D213/89 , C07D231/40 , C07D231/50 , C07D237/22 , C07D333/36 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07F7/18 , C07D43/02 , C07D41/02
CPC分类号: C07D409/14 , C07C275/30 , C07C275/32 , C07D213/40 , C07D213/75 , C07D213/89 , C07D231/40 , C07D231/50 , C07D237/22 , C07D333/36 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07F7/1804
摘要: The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
摘要翻译: 本发明提供了新的吡啶基或苯基脲及其类似物,它们是人P2Y 1受体的选择性抑制剂。 本发明还提供了相同的各种药物组合物以及治疗对P2Y受体活性的调节作用的疾病的方法。
-
5.UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS 有权
标题翻译: P2Y1受体的尿素拮抗剂用于治疗血栓病症公开(公告)号:US20080280905A1
公开(公告)日:2008-11-13
申请号:US12117005
申请日:2008-05-08
申请人: Hannguang J. Chao , Huji Tuerdi , Timothy F. Herpin , Jaques Yves Roberge , Yalei Liu , R. Michael Lawrence , Robert P. Rehfuss , Charles G. Clark , Jennifer X. Qiao , Timur Gungor , Patrick Y. S. Lam , Tammy Wang , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Gilles Bouthillier , Dora M. Schnur
发明人: Hannguang J. Chao , Huji Tuerdi , Timothy F. Herpin , Jaques Yves Roberge , Yalei Liu , R. Michael Lawrence , Robert P. Rehfuss , Charles G. Clark , Jennifer X. Qiao , Timur Gungor , Patrick Y. S. Lam , Tammy Wang , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Gilles Bouthillier , Dora M. Schnur
IPC分类号: A61K31/5377 , C07D213/72 , C07D413/12 , A61K31/4412 , A61K31/4439 , A61K31/4709 , A61P7/00 , A61P9/00 , A61K31/4725 , A61K31/444 , A61K31/4545 , A61K31/496 , C07D401/12
CPC分类号: C07D409/14 , C07C275/30 , C07C275/32 , C07D213/40 , C07D213/75 , C07D213/89 , C07D231/40 , C07D231/50 , C07D237/22 , C07D333/36 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07F7/1804
摘要: The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
摘要翻译: 本发明提供了新的吡啶基或苯基脲及其类似物,它们是人P2Y 1受体的选择性抑制剂。 本发明还提供了相同的各种药物组合物以及治疗对P2Y受体活性的调节作用的疾病的方法。
-
6.Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditions 有权
标题翻译: P2Y1受体的尿素拮抗剂可用于治疗血栓形成公开(公告)号:US07674828B2
公开(公告)日:2010-03-09
申请号:US12117005
申请日:2008-05-08
申请人: Hannguang J. Chao , Huji Tuerdi , Timothy F. Herpin , Jacques Y. Roberge , Yalei Liu , Michael R. Lawrence , Robert P. Rehfuss , Charles G. Clark , Jennifer X. Qiao , Timur Gungor , Patrick Y. S. Lam , Tammy C. Wang , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Gilles Bouthillier , Dora M. Schnur
发明人: Hannguang J. Chao , Huji Tuerdi , Timothy F. Herpin , Jacques Y. Roberge , Yalei Liu , Michael R. Lawrence , Robert P. Rehfuss , Charles G. Clark , Jennifer X. Qiao , Timur Gungor , Patrick Y. S. Lam , Tammy C. Wang , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Gilles Bouthillier , Dora M. Schnur
IPC分类号: A61K31/155 , C07C275/28
CPC分类号: C07D409/14 , C07C275/30 , C07C275/32 , C07D213/40 , C07D213/75 , C07D213/89 , C07D231/40 , C07D231/50 , C07D237/22 , C07D333/36 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07F7/1804
摘要: The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
摘要翻译: 本发明提供了作为人P2Y1受体的选择性抑制剂的新颖的吡啶基或苯基脲及其类似物。 本发明还提供了相同的各种药物组合物以及治疗对P2Y1受体活性调节作用的疾病的方法。
-
7.Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions 有权
标题翻译: P2Y1受体的尿素拮抗剂可用于治疗血栓形成公开(公告)号:US07388021B2
公开(公告)日:2008-06-17
申请号:US11126915
申请日:2005-05-10
申请人: Hannguang J. Chao , Huji Tuerdi , Timothy F. Herpin , Jacques Yves Roberge , Yalei Liu , R. Michael Lawrence , Robert P. Rehfuss , Charles G. Clark , Jennifer X. Qiao , Timur Gungor , Patrick Y. S. Lam , Tammy Wang , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Gilles Bouthillier , Dora M. Schnur
发明人: Hannguang J. Chao , Huji Tuerdi , Timothy F. Herpin , Jacques Yves Roberge , Yalei Liu , R. Michael Lawrence , Robert P. Rehfuss , Charles G. Clark , Jennifer X. Qiao , Timur Gungor , Patrick Y. S. Lam , Tammy Wang , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Gilles Bouthillier , Dora M. Schnur
IPC分类号: A61K31/4412 , A61K31/444 , C07D213/60 , C07D213/72
CPC分类号: C07D409/14 , C07C275/30 , C07C275/32 , C07D213/40 , C07D213/75 , C07D213/89 , C07D231/40 , C07D231/50 , C07D237/22 , C07D333/36 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07F7/1804
摘要: The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
摘要翻译: 本发明提供了新的吡啶基或苯基脲及其类似物,它们是人P2Y 1受体的选择性抑制剂。 本发明还提供了相同的各种药物组合物以及治疗对P2Y受体活性的调节作用的疾病的方法。
-
8.C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions 有权
标题翻译: P2Y1受体的C连接环状拮抗剂可用于治疗血栓形成公开(公告)号:US20060293336A1
公开(公告)日:2006-12-28
申请号:US11474899
申请日:2006-06-26
申请人: James Sutton , Jennifer Qiao , Carl Thibeault , Rejean Ruel
发明人: James Sutton , Jennifer Qiao , Carl Thibeault , Rejean Ruel
IPC分类号: A61K31/501 , A61K31/4439 , A61K31/427 , A61K31/423 , C07D417/02 , C07D413/02 , C07D403/02 , A61K31/4188
CPC分类号: C07D209/14 , C07C275/34 , C07C275/42 , C07C323/44 , C07C2601/02 , C07C2601/14 , C07D213/40 , C07D213/61 , C07D213/64 , C07D213/75 , C07D215/12 , C07D235/14 , C07D235/18 , C07D307/81 , C07D307/87 , C07D317/58 , C07D333/58 , C07D401/04 , C07D405/04 , C07D409/04 , C07D417/12
摘要: The present invention provides novel C-linked cyclic compounds and analogues of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, B, D and W are as defined herein. These compounds are selective inhibitors of the human P2Y1 receptor which can be used as medicaments.
摘要翻译: 本发明提供新的C连接的环状化合物和式(I)的类似物:或其立体异构体,互变异构体,药学上可接受的盐或溶剂化物形式,其中变量A,B,D和W如本文所定义。 这些化合物是可用作药物的人P2Y 1受体的选择性抑制剂。
-
9.C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions 有权
标题翻译: P2Y1受体的C连接环状拮抗剂可用于治疗血栓形成公开(公告)号:US07700620B2
公开(公告)日:2010-04-20
申请号:US11474899
申请日:2006-06-26
申请人: James C. Sutton , Jennifer X. Qiao , Carl Thibeault , Rejean Ruel
发明人: James C. Sutton , Jennifer X. Qiao , Carl Thibeault , Rejean Ruel
IPC分类号: A61K31/44 , C07D403/02
CPC分类号: C07D209/14 , C07C275/34 , C07C275/42 , C07C323/44 , C07C2601/02 , C07C2601/14 , C07D213/40 , C07D213/61 , C07D213/64 , C07D213/75 , C07D215/12 , C07D235/14 , C07D235/18 , C07D307/81 , C07D307/87 , C07D317/58 , C07D333/58 , C07D401/04 , C07D405/04 , C07D409/04 , C07D417/12
摘要: The present invention provides novel C-linked cyclic compounds and analogues of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, B, D and W are as defined herein. These compounds are selective inhibitors of the human P2Y1 receptor which can be used as medicaments.
摘要翻译: 本发明提供新的C连接的环状化合物和式(I)的类似物:或其立体异构体,互变异构体,药学上可接受的盐或溶剂化物形式,其中变量A,B,D和W如本文所定义。 这些化合物是可用作药物的人P2Y1受体的选择性抑制剂。
-
公开(公告)号:US20150274744A1
公开(公告)日:2015-10-01
申请号:US14440085
申请日:2013-10-31
申请人: Carl THIBEAULT , Jean RANCOURT , Pierre L. BEAULIEU , Anne DECOR , Chantal GRAND-MAITRE , Cyille KUHN , Elisia VILLEMURE , Melissa LEBLANC , Jene-Eric LACOSTE , Benoit MOREAU , Eric JOLICOEUR , Simon SURPRENANT , Oliver HUCKE
发明人: Carl Thibeault , Jean Rancourt , Pierre L. Beaulieu , Anne Décor , Chantal Grand-Maitre , Cyrille Kuhn , Elisia Villemure , Oliver Hucke , Simon Surprenant , Melissa Leblanc , Jean-Eric Lacoste , Benoit Moreau , Eric Jolicoeur
IPC分类号: C07D491/107 , C07D401/14 , C07D471/10 , C07D413/14 , C07D403/14 , C07D403/06
CPC分类号: C07D491/107 , C07D401/14 , C07D403/06 , C07D403/08 , C07D403/14 , C07D413/14 , C07D471/04 , C07D471/10 , C07D487/10
摘要: Compounds of Formula (I) wherein R1, R2, R3A, R3B, Y, Z1 and Z2 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
摘要翻译: 其中R1,R2,R3A,R3B,Y,Z1和Z2在本文中定义的式(I)化合物可用于治疗巨细胞病毒疾病和/或感染。
-
-
-
-
-
-
-
-
-